ARCHIVES

Toxic Substance Act Would Affect Cancer Program

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | March 21, 1975

Download PDF Visit The Full Archive

Related Articles

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

November 16, 2012

ASCO Annual Report Names Significant Clinical Research Advances Of Past Year

December 25, 2009

Modeling Will Be Used For Other Populations

November 26, 2010

Boston Meeting To Look At “IRBs At Crsswoad”

August 12, 1988

High Radiation Dose Effective Ten Years After Treatment

November 28, 2003

In Brief: US Pharmacopeia Names Advisory Panel For Hematologic And Oncological Disease

May 31, 1996